Table 3.

TNM and AMES wise survival

Risk group	5-year RFS in PDA	5-year OS in PDA	5-year RFS in PDC	5-year OS in PDC
TNM
< 55 years
Stage I	100%	100%		88%
Stage II	96%	97%		42%
>55 years
Stage I     Stage II     Stage III     Stage IV	100% 96% 85% 82%	100% 100% 89% 90%	58% 45% 38% 28%	62% 50% 45% 34%
AMES
Low risk	100%	100%	56%	60%
High risk	88%	90%	34%	40%
Overall 5 year survival	90%	93%	42%	44%

*This table shows the recurrence-free survival (RFS) and overall survival (OS) rates depicted by Kaplan-Meier/Log-rank curves in Fig. 1